Overview

Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen. This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product compared with the acetaminophen. Total of 96 patients with body temperature between 37.8-38.5 without any signs of infections will be enrolled in this study. Patients will be randomly divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr, Second group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third group will receive placebo twice daily.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Acetaminophen